Global Type 2 Diabetes Treatment Market - Upcoming Trends, Growth Drivers And Challenges – Forecast To 2018-2023
A new
market study, “Global Type 2 Diabetes Treatment Market - Upcoming
Trends, Growth Drivers And Challenges – Forecast To 2018-2023” has been featured on WiseGuyReports.
Type 2 diabetes is a long-term disorder characterized by the
resistance of the insulin and relative shortage of insulin. Increased
dehydration, sudden weight loss, and frequent urination are some of the
symptoms of type 2 diabetes. Type 2 diabetes occurs mainly due to obesity and
lack of exercise. However, it is preventable partly by eating properly,
maintaining a normal weight, and exercising regularly. The factors contributing
to the growth of the market include the increasing prevalence of type 2
diabetes especially in emerging economies such as India and China. Apart from
these supportive government initiatives and programs for type 2 diabetes
diagnosis and treatment is contributing significantly to the growth of the
market. Other factors driving the market growth include rising obesity coupled
with the aging population due to changing lifestyles of the people and rising demand
for non-invasive monitoring devices. However, there are factors such as the
high cost of the diagnosis and treatment therapies for diabetes and a strict
regulatory framework that hamper the growth of the global type 2 diabetes
market.
Based on the region, the global type 2 diabetes market is divided into North
America, Europe, Asia-Pacific and Rest of the World. North America dominates
the global type 2 diabetes market owing to technological advancements and
supportive government initiatives in this region. Asia-Pacific is anticipated
to witness a strong growth due to the high number of diabetics along with
increasing obesity, geriatric population, and changing lifestyles of the
people.
The companies contributing to the growth of global type 2
diabetes market are Abbott Laboratories, Inc. Bayer AG, Eli Lilly and Co.,
GlaxoSmithKline, PLC, Johnson & Johnson Services, Inc., Merck & Co.,
and Pfizer Inc. These players in the market are adopting various strategies
such as acquisition or entering into strategic alliance with other major
players from the market in order to gain a competitive edge over others and
enhance their presence.
Research methodology
The market study of type 2 diabetes market is incorporated by extensive primary
and secondary research conducted by the research team at OMR. Secondary
research has been conducted to refine the available data to breakdown the
market in various segments, derive total market size, market forecast, and
growth rate. Different approaches have been worked on to derive the market
value and market growth rate. Our team collects facts and data related to the
market from different geography to provide a better regional outlook. In the
report, the country-level analysis is provided by analyzing various regional
players, regional tax laws and policies, consumer behavior, and macro-economic
factors. Numbers extracted from secondary research have been authenticated by
conducting proper primary research. It includes tracking down key people from
the industry and interviewing them to validate the data. This enables our
analyst to derive the closest possible figures without any major deviations in
the actual number. Our analysts try to contact as many executives, managers,
key opinion leaders, and industry experts. Primary research brings the
authenticity in our reports
Secondary sources include
• Financial reports of companies involved in the
market
• Authentic Public Databases
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog
The report is intended for drug manufacturers,
healthcare provider, government organizations for overall market analysis, and
competitive analysis. The report will serve as a source for 360-degree analysis
of the market thoroughly integrating different models delivering insights into
the market for better business decisions.
Market segmentation
1. Global Type2 Diabetes Market Research and
Analysis by Drug Class
2. Global Type2 Diabetes Market Research and
Analysis by Devices
The report covers
• Comprehensive research methodology of the
global type2 diabetes market.
• This report also includes a detailed and
extensive market overview with analyst insights & key market trends.
• An exhaustive analysis of macro and micro
factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other
government policies impacting the global type2 diabetes market.
• Insights about market determinants which are
stimulating the global type2 diabetes market.
• Detailed and extensive market segments with
regional distribution of forecasted revenues.
• Extensive profiles and recent developments of
market players.
Companies Mentioned
1. Abbott Laboratories, Inc.
2. AstraZeneca, PLC
3. Bayer AG
4. Becton, Dickinson and Co.
5. Boehringer Ingelheim International GmbH
6. Dexcom, Inc.
7. Eli Lilly and Co.
8. F. Hoffmann-La Roche Ltd.
9. GlaxoSmithKline, PLC
10. Johnson And Johnson Services, Inc.
11. LifeScan, Inc.
12. Medtronic, PLC
13. Merck & Co., Inc
14. Novo-Nordisk A/S
15. Pfizer, Inc.
16. Sanofi S.A.
17. Smiths Medical, Inc.
18. Takeda Pharmaceutical, Ltd.
19. Tandem Diabetes Care, Inc.
20. ViaCyte, Inc
FOR MORE
DETAILS: https://www.wiseguyreports.com/reports/3739581-global-type-2-diabetes-treatment-market-research-and-forecast-2018-2023
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment